Literature DB >> 17041923

A novel G106D alteration of the SDHD gene in a pedigree with familial paraganglioma.

Kazumi Ogawa1, Kiyoto Shiga, Shigeru Saijo, Takenori Ogawa, Noriko Kimura, Akira Horii.   

Abstract

Head and neck paragangliomas are tumors derived from parasympathetic paraganglia. Familial cases account for 10% or more of these tumors, and mutations of the genes encoding subunits for the mitochondrial respiratory chain complex II, SDHD, SDHB, and SDHC, have been reported. We analyzed mutations in the all four SDH genes, SDHA through SDHD, in a Japanese family with cervical paraganglioma that include a father with bilateral tumors and his daughter with a malignant left carotid body tumor with nodal metastasis. This pedigree harbored a germline G106D alteration in exon 4 of the SDHD gene that has not previously been reported to date. The tumors of the father expressed biallelic SDHD, but the SDHD expression was highly suppressed by an unknown mechanism(s) in tumors of his daughter, and the wild-type allele was predominantly suppressed in the metastatic node. These results suggest that the missense dysfunction of SDHD prepares neoplastic condition and that expressional silencing, particularly of the wild-type allele, plays an important role in the malignant transformation of the paragangliomas. Our results may lead to a better understanding of this disease and to the development of methods for prevention of this disease. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041923     DOI: 10.1002/ajmg.a.31444

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

1.  Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma.

Authors:  Takenori Ogawa; Kazumi Ogawa; Kiyoto Shiga; Toru Furukawa; Hiroki Nagase; Sho Hashimoto; Toshimitsu Kobayashi; Akira Horii
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-05       Impact factor: 2.503

2.  Multi-institutional survey of carotid body tumors in Japan.

Authors:  Aya Ikeda; Kiyoto Shiga; Katsunori Katagiri; Daisuke Saito; Jun Miyaguchi; Shin-Ichi Oikawa; Kodai Tsuchida; Takahiro Asakage; Hiroyuki Ozawa; Ken-Ichi Nibu; Naoki Ohtsuki; Yasushi Fujimoto; Ken-Ichi Kaneko
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

3.  Familial cervical paragangliomas with lymph node metastasis expressing somatostatin receptor type 2A.

Authors:  Noriko Kimura; Hiroo Tateno; Shigeru Saijo; Akira Horii
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

Review 4.  [Dignity of carotid body tumors. Review of the literature and clinical experiences].

Authors:  D Grotemeyer; S M Loghmanieh; S Pourhassan; T A Sagban; F Iskandar; P Reinecke; W Sandmann
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

Review 5.  SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.

Authors:  B Pasini; C A Stratakis
Journal:  J Intern Med       Date:  2009-07       Impact factor: 8.989

Review 6.  Clinical aspects of SDHx-related pheochromocytoma and paraganglioma.

Authors:  Henri J L M Timmers; Anne-Paule Gimenez-Roqueplo; Massimo Mannelli; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2009-02-03       Impact factor: 5.678

7.  Neck paraganglioma and follicular lymphoma: a case report.

Authors:  Lara Marchetti; Luca Perrucci; Francesca D'Ercole; Maria Chiara Zatelli; Maria Rosaria Ambrosio; Melchiore Giganti; Aldo Carnevale
Journal:  J Med Case Rep       Date:  2019-12-20

Review 8.  Paragangliomas/Pheochromocytomas: clinically oriented genetic testing.

Authors:  Rute Martins; Maria João Bugalho
Journal:  Int J Endocrinol       Date:  2014-05-12       Impact factor: 3.257

9.  Targeted TET oxidase activity through methyl-CpG-binding domain extensively suppresses cancer cell proliferation.

Authors:  Yasuhiko Mizuguchi; Yuriko Saiki; Akira Horii; Shinichi Fukushige
Journal:  Cancer Med       Date:  2016-07-25       Impact factor: 4.452

10.  Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.

Authors:  Kanchan Chakma; Zhaodi Gu; Yakefujiang Abudurexiti; Tatsuo Hata; Fuyuhiko Motoi; Michiaki Unno; Akira Horii; Shinichi Fukushige
Journal:  Cancer Sci       Date:  2020-10-14       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.